Gene · 64332
Papers1,512
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,512
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of IkappaB Protein Expression by Early Gestation in the Thymus of Ewes. | Vet Sci | 2023 | 37505866 | PubTator, text mining | PubMed |
| Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro. | Nat Immunol | 2023 | 37500887 | PubTator, text mining | PubMed |
| Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering. | Sci Adv | 2023 | 37494448 | PubTator, text mining | PubMed |
| Vitamin D supplementation reduced blood inflammatory cytokines expression and improved graft function in kidney transplant recipients. | Front Immunol | 2023 | 37483634 | PubTator, text mining | PubMed |
| Peripheral blood biomarkers predict viral rebound following antiretroviral therapy discontinuation in SIV-infected, early ART-treated rhesus macaques. | Cell Rep Med | 2023 | 37467721 | PubTator, text mining | PubMed |
| The latest breakthrough on genetic characteristics of inflammatory bowel disease in Chinese and other East Asian ancestries. | Precis Clin Med | 2023 | 37456986 | PubTator, text mining | PubMed |
| Investigating the Crime Scene-Molecular Signatures in Inflammatory Bowel Disease. | Int J Mol Sci | 2023 | 37446397 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Bursting Dynamics Based on the Persistent Na+ and Na+/K+ Pump Currents: A Dynamic Clamp Approach. | eNeuro | 2023 | 37433684 | PubTator, text mining | PubMed |
| The central inflammatory regulator IκBζ: induction, regulation and physiological functions. | Front Immunol | 2023 | 37377955 | PubTator, text mining | PubMed |
| Lost and Found: The Family of NF-κB Inhibitors Is Larger than Assumed in Salmonid Fish. | Int J Mol Sci | 2023 | 37373375 | PubTator, text mining | PubMed |
| Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine. | Int J Mol Sci | 2023 | 37372997 | PubTator, text mining | PubMed |
| Sertoli Cells Express Accommodation, Survival, and Immunoregulatory Factors When Exposed to Normal Human Serum. | Biomedicines | 2023 | 37371745 | PubTator, text mining | PubMed |
| Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders. | Cells | 2023 | 37371095 | PubTator, text mining | PubMed |
| The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. | Cancers (Basel) | 2023 | 37370720 | PubTator, text mining | PubMed |
| Shining a light on the dark proteome: Non-canonical open reading frames and their encoded miniproteins as a new frontier in cancer biology. | Protein Sci | 2023 | 37350227 | PubTator, text mining | PubMed |
| [What do health care professionals know about advance directives?] | Dtsch Med Wochenschr | 2023 | 37327811 | PubTator, text mining | PubMed |
| Mitochondrial control of innate immune responses. | Front Immunol | 2023 | 37325622 | PubTator, text mining | PubMed |
| Primary central nervous system lymphoma. | Nat Rev Dis Primers | 2023 | 37322012 | PubTator, text mining | PubMed |
| Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease. | Cancer Cell | 2023 | 37311413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64332/papers?page=9